SCHEMBL8801276

SCHEMBL8801276

Cc1nc2c(c(-c3ccc(Cl)cc3)c1C)C(=O)OC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 1/20 0.37
LMNA P02545 4/20 0.37
HTT P42858 4/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 2/20 0.36
NCOA1 Q15788 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
BRD4 O60885 3/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
USP2 O75604 1/20 0.35
FPR1 P21462 1/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
CRHBP P24387 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8802745 0.86 MEN1 (0.55) KMT2AMEN1NPC1RAB9ALMNA
SCHEMBL7983845 0.80 LMNA (0.50) KMT2AMEN1SMN1; SMN2NPC1RAB9A
SCHEMBL8803269 0.80 LMNA (0.39) KMT2AMEN1SMN1; SMN2NPC1RAB9A
SCHEMBL8802957 0.79 ESRRB (0.38) KMT2ASMN1; SMN2NPC1RAB9AHTT
SCHEMBL29249095 0.76 MEN1 (0.51) KMT2AMEN1SMN1; SMN2NPC1RAB9A
SCHEMBL31643682 0.73 NUAK1 (0.36) KMT2AMEN1HTTALDH1A1KDM4E
SCHEMBL15444574 0.71 NUAK1 (0.35) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL29249103 0.69 ESR1 (0.52) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL29249066 0.68 MEN1 (0.51) KMT2AMEN1SMN1; SMN2NPC1RAB9A
SCHEMBL9693861 0.64 ALDH1A1 (0.54) KMT2AMEN1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0778769-A1 USE OF 5-SUBSTITUTED PYRIDINE AND HEXAHYDROQUINOLINE-3 CARBOXYLIC ACID DERIVATIVES FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM BAYER AG (DE) 1997-06-18 EP claimed
WO-1996006610-A1 USE OF 5-SUBSTITUTED PYRIDINE AND HEXAHYDROQUINOLINE-3 CARBOXYLIC ACID DERIVATIVES FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM BAYER AKTIENGESELLSCHAFT (DE) 1996-03-07 WO claimed